Abstract
Hybrid imaging devices including PET/CT and SPECT/CT have seen a great success since these scanners found their way into clinical routine – although this success is mainly based on the use in oncological imaging. But also the advent of PET/MRI holds great promise. The combined assessment of molecular imaging and morphology making use of the variety of PET tracers and the high spatial resolution from CT or MRI has the potential of an increased diagnostic accuracy all imaging but especially in cardiovascular questions. We put special emphasis on PET/MR although the experience is still limited. However, as the use of MR imaging in the assessment of myocardial viability as a prime example where assessing myocardial metabolism – even if done so indirectly - is so widespread in clinical reality, this appears to be justified. Thus, in this review, we aim to outline technical characteristics of hybrid imaging systems and highlight their use in cardiovascular diseases and their applications.
Keywords: PET, cardiac imaging, metabolism, perfusion, hybrid imaging, PET/MR, PET/CT, attenuation correction, workflows, dynamic imaging.
Current Pharmaceutical Design
Title:Assessing Myocardial Metabolism with Hybrid PET Imaging: Instrumentation, Concepts, and Workflows
Volume: 22 Issue: 1
Author(s): Stephan G. Nekolla and Christoph Rischpler
Affiliation:
Keywords: PET, cardiac imaging, metabolism, perfusion, hybrid imaging, PET/MR, PET/CT, attenuation correction, workflows, dynamic imaging.
Abstract: Hybrid imaging devices including PET/CT and SPECT/CT have seen a great success since these scanners found their way into clinical routine – although this success is mainly based on the use in oncological imaging. But also the advent of PET/MRI holds great promise. The combined assessment of molecular imaging and morphology making use of the variety of PET tracers and the high spatial resolution from CT or MRI has the potential of an increased diagnostic accuracy all imaging but especially in cardiovascular questions. We put special emphasis on PET/MR although the experience is still limited. However, as the use of MR imaging in the assessment of myocardial viability as a prime example where assessing myocardial metabolism – even if done so indirectly - is so widespread in clinical reality, this appears to be justified. Thus, in this review, we aim to outline technical characteristics of hybrid imaging systems and highlight their use in cardiovascular diseases and their applications.
Export Options
About this article
Cite this article as:
G. Nekolla Stephan and Rischpler Christoph, Assessing Myocardial Metabolism with Hybrid PET Imaging: Instrumentation, Concepts, and Workflows, Current Pharmaceutical Design 2016; 22 (1) . https://dx.doi.org/10.2174/1381612822666151109112519
DOI https://dx.doi.org/10.2174/1381612822666151109112519 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Arterial Ischemic Stroke in Neonates and Children: Review and Current Issues
Current Pediatric Reviews Mechanical Circulatory Support of the Critically Ill Child Awaiting Heart Transplantation
Current Cardiology Reviews The Future of Diabetes Management by Healthy Probiotic Microorganisms
Current Diabetes Reviews Severe Preeclampsia
Current Women`s Health Reviews A Review on Electrocardiographic Changes in Diabetic Patients
Current Diabetes Reviews Advances in L-Type Calcium Channel Structures, Functions and Molecular Modeling
Current Medicinal Chemistry Chromogranin-A: A Multifaceted Cardiovascular Role in Health and Disease
Current Medicinal Chemistry Blood Pressure Variability and Mortality in end Stage Renal Disease
Current Hypertension Reviews Thiazolidinediones and Cardiovascular Risk — A Question of Balance
Current Cardiology Reviews Patent Selections:
Recent Patents on Nanotechnology Innovative Strategy in Treating Angina Pectoris with Chinese Patent Medicines by Promoting Blood Circulation and Removing Blood Stasis: Experience from Combination Therapy in Chinese Medicine
Current Vascular Pharmacology Clinical Management of Arrhythmogenic Right Ventricular Cardiomyopathy: An Update
Current Pharmaceutical Design Mechanical Support in Cardiogenic Shock Complicating Acute Coronary Syndrome: Ready for Prime Time?
Current Vascular Pharmacology Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Current Clinical Pharmacology Intravenous Antihypertensives within Cardiovascular-Based Continuity of Care
Current Vascular Pharmacology Patent Foramen Ovale, the Role of Antiplatelet Therapy Alone or Anticoagulant Therapy Alone Versus Device Closure for Cryptogenic Stroke: A Review of the Literature and Current Recommendations
Cardiovascular & Hematological Agents in Medicinal Chemistry Methods for Docking Small Molecules to Macromolecules: A User’s Perspective. 2. Applications
Current Pharmaceutical Design Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Current Pharmaceutical Design The Relationship Between Cleft Lip, Maxillary Hypoplasia, Hypoxia and Phenytoin
Current Pharmaceutical Design Comparison Between the Effects of Bupivacaine and Levobupivacaine for Spinal Anesthesia on QT Dispersion
Cardiovascular & Hematological Disorders-Drug Targets